Lead in Birds

Lead is a highly toxic heavy metal that acts as a nonspecific poison affecting all body systems and has no known biological requirement. Absorption of low concentrations may result in a wide range of sublethal effects in animals, and higher concentrations may result in mortality (Demayo et al. 1982). Lead has been mined and smelted by humans for centuries, but the use of lead-based products increased greatly following the Industrial Revolution. Consequently, lead today is ubiquitous in air, water, and soil, in both urban and rural environments (Eisler 2000). Vertebrates are exposed to lead mainly via inhalation and ingestion. A proportion of lead entering the body is absorbed into the bloodstream and subsequently becomes distributed among body tissues, primarily the blood, liver, kidney, and bone. As a result of anthropogenic activities, most animals have higher tissue lead concentrations than in preindustrialized times. Although even very low tissue lead concentrations have some measurable physiological effects, the concentrations usually encountered in the wider environment (i.e., distant from lead emission sources) have not generally been considered to directly affect survival of most wildlife

Lead in Birds

Lead is a highly toxic heavy metal that acts as a nonspecific poison affecting all body systems and has no known biological requirement. Absorption of low concentrations may result in a wide range of sublethal effects in animals, and higher concentrations may result in mortality (Demayo et al. 1982). Lead has been mined and smelted by humans for centuries, but the use of lead-based products increased greatly following the Industrial Revolution. Consequently, lead today is ubiquitous in air, water, and soil, in both urban and rural environments (Eisler 2000). Vertebrates are exposed to lead mainly via inhalation and ingestion. A proportion of lead entering the body is absorbed into the bloodstream and subsequently becomes distributed among body tissues, primarily the blood, liver, kidney, and bone. As a result of anthropogenic activities, most animals have higher tissue lead concentrations than in preindustrialized times. Although even very low tissue lead concentrations have some measurable physiological effects, the concentrations usually encountered in the wider environment (i.e., distant from lead emission sources) have not generally been considered to directly affect survival of most wildlife

Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS—results from a single centre study in the UK

BackgroundPaediatric symptomatic SARS-CoV-2 infections associate with two presentations, acute COVID-19 and paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). Phenotypic comparisons, and reports on predictive markers for disease courses are sparse and preliminary.MethodsA chart review of COVID-19 and PIMS-TS patients (≤19 years) admitted to Alder Hey Children's NHS Foundation Trust, a tertiary centre in the North-West of England, was performed (02/2020–09/2022).ResultsA total of 161 symptomatic COVID-19 and 50 PIMS-TS patients were included. Peaks in admissions of patients with PIMS-TS occurred approximately 4 weeks after those for acute COVID-19. The incidence of in-patients with PIMS-TS reduced over time, and there were no admissions after February 2022. When compared to acute COVID-19, PIMS-TS patients were older (median: 10.3 years vs. 2.03 years; p < 0.001). There were no differences in gender distribution, but minority ethnicities were over-represented among PIMS-TS patients. Regional ethnic distribution was reflected among acute COVID-19 patients (66% vs. 84.5% White Caucasian, p = 0.01). Pre-existing comorbidities were more common among acute COVID-19 patients (54.7% vs. 8%, p < 0.001). PIMS-TS patients more commonly presented with abdominal symptoms (92% vs. 50.3%), neurological symptoms (28% vs. 10.6%) and skin rashes (72% vs. 16.8%), (p ≤ 0.01) when compared with acute COVID-19, where respiratory symptoms were more common (51.6% vs. 32%, p = 0.016). PIMS-TS more frequently required intensive care admission (64% vs. 16.8%), and inotropic support (64% vs. 9.3%) (all p < 0.05). More deaths occurred among acute COVID-19 patients [0 vs. 7 (4.4%)], with 5/7 (71%) in the context of pre-existing comorbidities. When compared to acute COVID-19, PIMS-TS patients exhibited more lymphopenia and thrombocytopenia, a more pronounced acute phase reaction, and more hyponatraemia (p < 0.05). Partial least square discriminant analysis of routine laboratory parameters allowed (incomplete) separation of patients at diagnosis, and variable importance projection (VIP) scoring revealed elevated CRP and low platelets as the most discriminatory parameters.ConclusionAdmissions for PIMS-TS reduced with increasing seroconversion rates in the region. Young age and pre-existing comorbidities associate with hospital admission for acute COVID-19. While PIMS-TS may present more acutely with increased need for intensive care, acute COVID-19 had an increased risk of mortality in this cohort

PIXSIC: A Wireless Intracerebral Radiosensitive Probe in Freely Moving Rats

International audienceThe aim of this study was to demonstrate the potential of a wireless pixelated β+-sensitive intracerebral probe (PIXSIC) for in vivo positron emission tomographic (PET) radiopharmacology in awake and freely moving rodents. The binding of [ 11 C]raclopride to D 2 dopamine receptors was measured in anesthetized and awake rats following injection of the radiotracer. Competitive binding was assessed with a cold raclopride injection 20 minutes later. The device can accurately monitor binding of PET ligands in freely moving rodents with a high spatiotemporal resolution. Reproducible time-activity curves were obtained for pixels throughout the striatum and cerebellum. A significantly lower [ 11 C]raclopride tracer–specific binding was observed in awake animals. These first results pave the way for PET tracer pharmacokinetics measurements in freely moving rodents

Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C

© 2007 Plant et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens

Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS-results from a single centre study in the UK.

BackgroundPaediatric symptomatic SARS-CoV-2 infections associate with two presentations, acute COVID-19 and paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). Phenotypic comparisons, and reports on predictive markers for disease courses are sparse and preliminary.MethodsA chart review of COVID-19 and PIMS-TS patients (≤19 years) admitted to Alder Hey Children's NHS Foundation Trust, a tertiary centre in the North-West of England, was performed (02/2020-09/2022).ResultsA total of 161 symptomatic COVID-19 and 50 PIMS-TS patients were included. Peaks in admissions of patients with PIMS-TS occurred approximately 4 weeks after those for acute COVID-19. The incidence of in-patients with PIMS-TS reduced over time, and there were no admissions after February 2022. When compared to acute COVID-19, PIMS-TS patients were older (median: 10.3 years vs. 2.03 years; p p = 0.01). Pre-existing comorbidities were more common among acute COVID-19 patients (54.7% vs. 8%, p p ≤ 0.01) when compared with acute COVID-19, where respiratory symptoms were more common (51.6% vs. 32%, p = 0.016). PIMS-TS more frequently required intensive care admission (64% vs. 16.8%), and inotropic support (64% vs. 9.3%) (all p p ConclusionAdmissions for PIMS-TS reduced with increasing seroconversion rates in the region. Young age and pre-existing comorbidities associate with hospital admission for acute COVID-19. While PIMS-TS may present more acutely with increased need for intensive care, acute COVID-19 had an increased risk of mortality in this cohort

A systematic review of the experience, occurrence, and controllability of flow states in elite sport

Objectives: This study aimed to provide an up-to-date summary of the literature on flow in elite sport, specifically relating to: (i) how flow is experienced; (ii) how these states occur; and (iii) the potential controllability of flow. Design: Systematic review. Methods: A comprehensive literature search of SPORTdiscus, PsycINFO, SAGE journals online, INGENTA connect, and Web of Knowledge was completed in August, 2011, and yielded 17 empirical studies published between 1992 and 2011. The primarily qualitative findings were analysed thematically and synthesised using a narrative approach. Results: Findings indicated that: (i) some flow dimensions appear to be experienced more consistently than others; (ii) key factors were consistently reported to induce or inhibit flow occurrence; and (iii) the perception that flow experiences could be controllable to some extent, and are not merely ‘coincidental’. Additionally, it is appears that physiology is also relevant in flow, and these experiences may be psychophysiological. Conclusions: Based on these findings, recommendations are made including the need for researchers to move from description to explanation of flow, the use of new methodologies, greater focus on the role of personality factors, and possible refinements of existing flow theory to be more specific to sport